Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

18F-DCFPyL PSMA-PET Imaging for the Detection of Early Metastatic Prostate Cancer in Patients with High GC Test Scores, A Sub-aim of the VANDAAM Study (MCC #18523)

Trial Status: active

This phase II/III trial studies how well 18F-DCFPyL PSMA-PET imaging works in detecting early prostate cancer that has spread to other places in the body (metastatic) in patients with high GC test scores. Diagnostic procedures such as 18F-DCFPyL PSMA-PET imaging, may improve the ability to detect early metastatic disease in prostate cancer patients with a high GC and ultimately help doctors in planning the optimal course of treatment for the disease.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.